No Data
Optimistic Investors Push Baijin Life Science Holdings Limited (HKG:1466) Shares Up 28% But Growth Is Lacking
Baijin Life Science to Raise HK$31 Million Through Private Placement
Bai Jin Life Sciences (01466.HK) plans to issue 65.3594 million subscription shares, raising a total of 31.373 million Hong Kong dollars.
On March 18, Glonghui reported that Baijin Life Sciences (01466.HK) announced that on March 18, 2025, the company (as the issuer) entered into separate subscription agreements with subscribers to subscribe for a total of 65.3594 million subscription shares at a subscription price of HKD 0.48 per share. The subscription price is HKD 0.48 per subscription share, which is approximately 4.00% lower than the closing price of HKD 0.50 per share reported on March 18 (the date of the subscription agreement) on the Stock Exchange. The subscription shares to be allocated and issued under the subscription agreement correspond to about 9.24% of the existing issued share capital as of the date of this announcement.
Express News | Baijin Life Science Holdings Ltd - Issuance of 65.4 Mln Subscription Shares at HK$0.48 per Share
Affluent Partners Changes Name to Baijin Life Science
AFFLUENTPARTNER (01466) has been renamed to "Bai Jin Life Sciences Holdings Limited".
AFFLUENTPARTNER (01466) announced that it will pass special resolutions at the Shareholder's extraordinary general meeting to be held on November 26, 2024.